Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
143 participants
INTERVENTIONAL
2009-07-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age
NCT04061538
Effect of Prompting the Supply of Zinc/LO-ORS Co-packs in the Private Sector Plus BCI on Childhood Diarrhea Treatment
NCT04335877
Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years
NCT05002101
Zinc-MNP Trial for Prevention of Diarrhea and Promotion of Linear Growth
NCT03406793
A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial
NCT00374023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Micronutrient Sprinkles without zinc
Micronutrient sprinkles without zinc
Micronutrient sprinkles without zinc
I packet of micronutrient sprinkles without zinc
Micronutrient sprinkles with zinc
Micronutrient sprinkles with zinc gluconate
Micronutrient Sprinkles with zinc
Daily dose of 1 packet of sprinkles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Micronutrient Sprinkles with zinc
Daily dose of 1 packet of sprinkles
Micronutrient sprinkles without zinc
I packet of micronutrient sprinkles without zinc
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
4 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Bahia
OTHER
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Conrad R. Cole
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Conrad R Cole, MD, MPH, MSc
Role: PRINCIPAL_INVESTIGATOR
Emory University
Hugo Ribeiro Da Costa, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal da Bahia, Complexo Hospitalar Universitário Professor Edgar Santos, Centro de Pesquisa Fima Lifshitz, Salvador, Bahia, Brazil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal da Bahia, Complexo Hospitalar Universitário Professor Edgar Santos, Centro de Pesquisa Fima Lifshitz
Salvador, Estado de Bahia, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Imdad A, Rogner J, Sherwani RN, Sidhu J, Regan A, Haykal MR, Tsistinas O, Smith A, Chan XHS, Mayo-Wilson E, Bhutta ZA. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD009384. doi: 10.1002/14651858.CD009384.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00007903
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.